Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Background: Benzodiazepine use is widespread in older people, although its benefit is uncertain. Aim: To investigate the long-term effect of benzodiazepine use upon dementia risk. Methods: A prospective cohort of men seen on five occasions over 22 years with full medication histories, repeat measures of cognitive function and a clinical diagnosis of dementia. Results: Of 1134 men with complete data, 103 (9.1%) had been taking benzodiazepines regularly at one or more phases. These men showed a marked increased incidence of dementia (OR=3.50, 95% CI 1.57 to 7.79, p=0.002), which persisted despite adjustment for psychological distress and other covariates. Men exposed in earlier phases showed a greater association than more recent exposure, counter to what one would expect if this was due to reverse causation, though we failed to demonstrate a dose–response effect with drug duration. Conclusion: The taking of benzodiazepines is associated with an increased risk of dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
The FAB: A frontal assessment battery at bedside
Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) · Neurology · doi:10.1212/wnl.55.11.1621 · Cited by 3,913
Roth, M., Tym, E., Mountjoy, C. Q., Huppert, F. A., Hendrie, H., Verma, S., & Goddard, R. (1986) · British Journal of Psychiatry · doi:10.1192/bjp.149.6.698 · Cited by 2,090
(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis
Barker, M. (2004) · Archives of Clinical Neuropsychology · doi:10.1016/s0887-6177(03)00096-9 · Cited by 307 · cited 1×
“A third strain of evidence comes from pharmacological studies that have identified acute adverse cognitive effects of benzodiazepine use in older persons,(1) 12 which may persist for over 6 months after withdrawal of medication.(13) Further evidence is therefore required to establish whether benzodiazepine use has any…”
BackgroundDoes Anxiety Affect Risk of Dementia? Findings From the Caerphilly Prospective Study
Gallacher, J., Bayer, A., Fish, M., Pickering, J., Pedro, S., Dunstan, F., Ebrahim, S., & Ben-Shlomo, Y. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181a6177c · Cited by 137
Self-citationGallacher, J., Bayer, A., Lowe, G., Fish, M., Pickering, J., Pedro, S., Dunstan, F., White, J., Yarnell, J., & Ben-Shlomo, Y. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197368 · Cited by 63
Self-citationAllard, J., Artero, S., & Ritchie, K. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.891 · Cited by 60
Cited by
Benzodiazepine use and risk of Alzheimer's disease: case-control study
Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., & Begaud, B. (2014) · BMJ · doi:10.1136/bmj.g5205 · Cited by 558
Benzodiazepine use and risk of dementia: prospective population based study
Billioti de Gage, S., Begaud, B., Bazin, F., Verdoux, H., Dartigues, J.-F., Peres, K., Kurth, T., & Pariente, A. (2012) · BMJ · doi:10.1136/bmj.e6231 · Cited by 436
Loss of functional GABA A receptors in the Alzheimer diseased brain
Limon, A., Reyes-Ruiz, J. M., & Miledi, R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204606109 · Cited by 264
Weich, S., Pearce, H. L., Croft, P., Singh, S., Crome, I., Bashford, J., & Frisher, M. (2014) · BMJ · doi:10.1136/bmj.g1996 · Cited by 259
Gray, S. L., Dublin, S., Yu, O., Walker, R., Anderson, M., Hubbard, R. A., Crane, P. K., & Larson, E. B. (2016) · BMJ · doi:10.1136/bmj.i90 · Cited by 233
Lucchetta, R. C., da Mata, B. P. M., & Mastroianni, P. D. C. (2018) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2170 · Cited by 130
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
Baandrup, L., Ebdrup, B. H., Rasmussen, J. Ø., Lindschou, J., Gluud, C., & Glenthøj, B. Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011481.pub2 · Cited by 128
Association between daily sleep duration and risk of dementia and mortality in a Japanese community
Ohara, T., Honda, T., Hata, J., Yoshida, D., Mukai, N., Hirakawa, Y., Shibata, M., Kishimoto, H., Kitazono, T., Kanba, S., et al. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15446 · Cited by 111
Kroll, D. S., Nieva, H. R., Barsky, A. J., & Linder, J. A. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3740-0 · Cited by 94
“Mean (± SD) Patient age, years 51 (13) 55 (15) 0.”
Nafti, M., Sirois, C., Kröger, E., Carmichael, P.-H., & Laurin, D. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028019882037 · Cited by 73
“performance among benzodiazepine users.(5,8,13-16) Most of these studies assessed cognitive function on the basis of scores obtained with the use of global screening instruments and neuropsychological test batteries.”
BackgroundLähteenmäki, R., Puustinen, J., Vahlberg, T., Lyles, A., Neuvonen, P. J., Partinen, M., Räihä, I., & Kivelä, S.-L. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12294 · Cited by 54
Shih, H.-I., Lin, C.-C., Tu, Y.-F., Chang, C.-M., Hsu, H.-C., Chi, C.-H., & Kao, C.-H. (2015) · Medicine · doi:10.1097/md.0000000000000809 · Cited by 55
Dyer, A. H., Murphy, C., Lawlor, B., Kennelly, S. P., Lawlor, B., Segurado, R., Kennelly, S., Olde Rikkert, M. G. M., Howard, R., Pasquier, F., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.08.006 · Cited by 39
Lukačišinová, A., Fialová, D., Peel, N. M., Hubbard, R. E., Brkic, J., Onder, G., Topinková, E., Gindin, J., Shochat, T., Gray, L., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02213-x · Cited by 35
Lähteenmäki, R., Neuvonen, P. J., Puustinen, J., Vahlberg, T., Partinen, M., Räihä, I., & Kivelä, S. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13144 · Cited by 34
“Chronic BZDA use in older adults is associated with an increased risk of adverse outcome such as balance difficulties, falling, cognitive impairment, dementia and increased mortality.(5-13) Various strategies have been applied to improve the quality of hypnotic prescription and to withdraw BZDA hypnotics from their ch…”
BackgroundHsiao, F.-Y., Peng, L.-N., Lin, M.-H., & Chen, L.-K. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.02.009 · Cited by 20
Association Between the Use of Hypnotics and the Risk of Alzheimer's Disease
Jeong, W., Joo, J. H., Kim, H., Kim, Y. K., Park, E.-C., & Jang, S.-I. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201319 · Cited by 11
(2018) · Europe PMC (PubMed Central) · Cited by 10
Metadata
- Authors
- Gallacher, J., Elwood, P., Pickering, J., Bayer, A., Fish, M., & Ben-Shlomo, Y.
- Venue
- Journal of Epidemiology and Community Health
- Publisher
- BMJ
- Published
- 2011-10-27
- Volume
- 66
- Issue
- 10
- Pages
- 869-873
- ISSN
- 0141-7681 (ISSN-L)
- 0143-005X
- 1470-2738
- OpenAlex
- W2101264963
- Cited by
- 151
- References
- 8
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.